Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$8.7M
+25.7% from 2023
Prescriptions
1,028
$8,483.89 per claim
Patients
186
181 prescribers
Total spending, 2024
$8.7M
$46,718.61 per patient
Medicare prescription drug plans paid $8.7M for Lanreotide Acetate in 2024, for 1,028 prescriptions and refills to 186 patients (up 25.7% from 2023). The average cost per claim was $8,483.89.
California had the highest Medicare cost for Lanreotide Acetate in 2024: $1.0M for 130 claims, followed by New York ($911K).
Mouhamad Bazzi, hematology-oncology in Frederick, MD, had the highest Medicare cost for Lanreotide Acetate in 2024: 32 claims costing $290K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Mouhamad Bazzi Frederick, MD | Hematology-Oncology | 32 | Under 11 | $290K |
| Sanjaykumar J Hapani Edmond, OK | Medical Oncology | 33 | Under 11 | $258K |
| Fauzia Paracha |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 49 | 169 | 51 | $1.6M |
| 2023 | 120 | 714 | 122 | $6.9M |
| 2024 | 181 | 1,028 | 186 | $8.7M |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 29 |
| Under 11 |
| $247K |
| Mariann Harrington Little Rock, AR | Hematology-Oncology | 30 | Under 11 | $243K |
| Kewen Z Jauss Little Rock, AR | Hematology-Oncology | 18 | Under 11 | $150K |
| Stuart P Feldman White Plains, NY | Hematology-Oncology | 17 | Under 11 | $149K |
| Maria A Scouros Houston, TX | Hematology-Oncology | 16 | Under 11 | $126K |
| John W Dubay Tuscaloosa, AL | Hematology-Oncology | 14 | Under 11 | $123K |
| Rita K Pradhan Pomona, CA | Endocrinology | 15 | Under 11 | $120K |
| Swetha S Yadav Kearney, NE | Hematology-Oncology | 14 | Under 11 | $113K |
| David Bornstein Rancho Mirage, CA | Nurse Practitioner | 14 | Under 11 | $112K |
| Jamie Burton Little Rock, AR | Hematology | 14 | Under 11 | $111K |
| Paul J Ebbert Arapahoe, WY | Family Practice | 11 | Under 11 | $109K |
| John W Linford Missoula, MT | Hematology-Oncology | 13 | Under 11 | $104K |
| Dhiren A Shah Glenview, IL | Gastroenterology | 12 | Under 11 | $100K |
| Kamal Patel Little Rock, AR | Hematology-Oncology | 12 | Under 11 | $99K |
| Olatunji B Alese Atlanta, GA | Hematology-Oncology | 12 | Under 11 | $99K |
| Eugene J Wyszynski Farmers Branch, TX | Hematology-Oncology | 12 | Under 11 | $98K |
| David N Oubre Hammond, LA | Hematology-Oncology | 12 | Under 11 | $94K |
| Jun Ma Flushing, NY | Physician Assistant | 11 | Under 11 | $92K |
| Eddie Thara Downey, CA | Hematology-Oncology | 11 | Under 11 | $91K |
| Dhaval R Shah Newark, DE | Hematology-Oncology | 11 | Under 11 | $91K |
| Grace L Raja Little Rock, AR | Hematology-Oncology | 11 | Under 11 | $90K |
| Devarajan P Iyengar Bayonne, NJ | Internal Medicine | 11 | Under 11 | $90K |
| Ronald Tang Pasadena, CA | Hematology-Oncology | 11 | Under 11 | $89K |
| Manufacturer | Claims | Spending |
|---|---|---|
| Cipla USA, Inc. CIPLA.NS | 1,018 | $8.7M |
| Exelan Pharmace | 12 | $31K |